Clinical

Dataset Information

0

Phase 2 Study of ABX-EGF (Panitumumab) in Japanese Subjects With M-colorectal Cancer


ABSTRACT: The primary objective of this study is to assess the effect of treatment with ABX-EGF on best overall objective response rate by modified RECIST (confirmed complete or partial response) in Japanese subjects with metastatic colorectal cancer.

DISEASE(S): Metastatic Colorectal Cancer,Colorectal Cancer,Colorectal Neoplasms

PROVIDER: 2029020 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR

Similar Datasets

| 2012873 | ecrin-mdr-crc
2014-12-01 | GSE57547 | GEO
| 2013018 | ecrin-mdr-crc
2009-02-09 | GSE10585 | GEO
2010-05-06 | E-GEOD-10585 | biostudies-arrayexpress
| 2525060 | ecrin-mdr-crc
2016-07-25 | GSE69639 | GEO
2016-07-25 | E-GEOD-69639 | biostudies-arrayexpress
| PRJNA892124 | ENA
2010-04-14 | GSE15668 | GEO